| Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans |
| SA Rosenberg |
|
JCO Mar 1 1988: 403–406.
[PDF]
|
 |
| Infusions, age, and drug dosages: learning about large-cell lymphoma |
| JM Connors |
|
JCO Mar 1 1988: 407–408.
[PDF]
|
|
|
Effectiveness and tolerability of low-dose cyclophosphamide and low- dose intravenous interleukin-2 in disseminated melanoma [corrected] [published erratum appears in J Clin Oncol 1988 Jun;6(6):1067] |
| |
MS Mitchell, RA Kempf, W Harel, H Shau, WD Boswell, S Lind, and EC Bradley |
| |
JCO Mar 1 1988: 409–424.
[Abstract]
[PDF]
|
|
|
COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma |
| |
DB Boyd, M Coleman, SW Papish, A Topilow, SK Kopel, B Bernhardt, JC Files, S Schwartz, M Gaynor, and D McDermott |
| |
JCO Mar 1 1988: 425–433.
[Abstract]
[PDF]
|
|
|
The determination of an immunologically active dose of interferon-gamma in patients with melanoma |
| |
AE Maluish, WJ Urba, DL Longo, WR Overton, D Coggin, ER Crisp, R Williams, SA Sherwin, K Gordon, and RG Steis |
| |
JCO Mar 1 1988: 434–445.
[Abstract]
[PDF]
|
|
|
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer |
| |
KY Shum, MG Kris, RJ Gralla, MT Burke, LD Marks, and RT Heelan |
| |
JCO Mar 1 1988: 446–450.
[Abstract]
[PDF]
|
|
|
Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer |
| |
LH Einhorn, J Crawford, R Birch, G Omura, DH Johnson, and FA Greco |
| |
JCO Mar 1 1988: 451–456.
[Abstract]
[PDF]
|
|
|
A mathematical model of drug resistance applied to treatment for small- cell lung cancer |
| |
WM Gregory, BG Birkhead, and RL Souhami |
| |
JCO Mar 1 1988: 457–461.
[Abstract]
[PDF]
|
|
|
Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas |
| |
J Glenn, WM Steinberg, SH Kurtzman, SM Steinberg, and WF Sindelar |
| |
JCO Mar 1 1988: 462–468.
[Abstract]
[PDF]
|
|
|
A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma |
| |
C Erlichman, S Fine, A Wong, and T Elhakim |
| |
JCO Mar 1 1988: 469–475.
[Abstract]
[PDF]
|
|
|
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study |
| |
FM Torti, LD Shortliffe, RD Williams, WC Pitts, RL Kempson, JC Ross, J Palmer, F Meyers, M Ferrari, and J Hannigan |
| |
JCO Mar 1 1988: 476–483.
[Abstract]
[PDF]
|
|
|
Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance |
| |
JS Miser, TJ Kinsella, TJ Triche, M Tsokos, R Forquer, R Wesley, K Horvath, J Belasco, DL Longo, and R Steis |
| |
JCO Mar 1 1988: 484–490.
[Abstract]
[PDF]
|
|
|
Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children |
| |
M Gasparini, F Lombardi, L Rottoli, E Ballerini, and F Morandi |
| |
JCO Mar 1 1988: 491–494.
[Abstract]
[PDF]
|
|
|
High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia |
| |
PA Cassileth, LS Sylvester, JM Bennett, and CB Begg |
| |
JCO Mar 1 1988: 495–498.
[Abstract]
[PDF]
|
|
|
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study |
| |
RL Capizzi, R Davis, B Powell, J Cuttner, RR Ellison, MR Cooper, R Dillman, WB Major, E Dupre, and OR McIntyre |
| |
JCO Mar 1 1988: 499–508.
[Abstract]
[PDF]
|
|
|
Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma |
| |
Z Fuks, S Rizel, and S Biran |
| |
JCO Mar 1 1988: 509–516.
[Abstract]
[PDF]
|
|
|
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans |
| |
K Mross, P Maessen, WJ van der Vijgh, H Gall, E Boven, and HM Pinedo |
| |
JCO Mar 1 1988: 517–526.
[Abstract]
[PDF]
|
|
|
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers |
| |
AS Alberts, G Falkson, L Goedhals, DA Vorobiof, and CA Van der Merwe |
| |
JCO Mar 1 1988: 527–535.
[Abstract]
[PDF]
|
|
|
Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy |
| |
C Dy, FA Calvo, JP Mindan, LA Aparicio, SM Algarra, A Gil, F Gonzalez, and S Harguindey |
| |
JCO Mar 1 1988: 536–542.
[Abstract]
[PDF]
|
|
| Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review |
| DE Weissman |
|
JCO Mar 1 1988: 543–551.
[PDF]
|
|
|
Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy? |
| |
DG Payne |
| |
JCO Mar 1 1988: 552–558.
[Abstract]
[PDF]
|
|
| Guidelines for reporting outcomes of lymphoma trials |
| JR Anderson, KJ Propert, and DP Harrington |
|
JCO Mar 1 1988: 559–560.
[PDF]
|
|
| Acute leukemia and pregnancy |
| A Aviles |
|
JCO Mar 1 1988: 560–561.
[PDF]
|
|
| Rethinking medical oncology training and education |
| FL Meyskens, Jr |
|
JCO Mar 1 1988: 561–562.
[PDF]
|
|
